Emergent BioSolutions Inc.
EBS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367644
In the last 90 days, Emergent BioSolutions Inc. insiders filed 0 open-market purchases and 1 sale; 194 institutions reported holding it in 13F filings for Q2 2026, worth $373.6M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Emergent BioSolutions Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 190
- +11 vs. Q4 2025
- Shares held
- 43.4M
- +3.71M (+9.3%) vs. Q4 2025
- Total value
- $360.7M
- −$130.3M (−26.5%) vs. Q4 2025
- New holders
- 37
- 70 more added
- Sold out
- 26
- 53 more reduced
4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EBS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 194 | $373.6M |
| Q1 2026 | 190 | $360.7M |
| Q4 2025 | 183 | $536.5M |
| Q3 2025 | 169 | $352.5M |
| Q2 2025 | 161 | $240.9M |
| Q1 2025 | 161 | $176.1M |
| Q4 2024 | 156 | $332.0M |
| Q3 2024 | 140 | $264.5M |
| Q2 2024 | 141 | $207.5M |
| Q1 2024 | 121 | $90.8M |
| Q4 2023 | 134 | $98.2M |
| Q3 2023 | 163 | $140.8M |
| Q2 2023 | 183 | $336.2M |
| Q1 2023 | 192 | $465.3M |
| Q4 2022 | 198 | $545.8M |
| Q3 2022 | 211 | $852.4M |
| Q2 2022 | 233 | $1.28B |
| Q1 2022 | 254 | $1.72B |
| Q4 2021 | 254 | $1.86B |
| Q3 2021 | 277 | $2.23B |
| Q2 2021 | 290 | $2.82B |
| Q1 2021 | 340 | $4.14B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Emergent BioSolutions Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,910−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −22,482−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −14,011−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −11,432−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −11,235−100.0% | Sold out |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Kemnay Advisory Services Inc. | 0 | $0 | 0.00% | −8,660−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −3,645−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,639−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −1,549−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Optima Capital LLC | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| SHP Wealth Management | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Brandywine Global Investment Management, LLC | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |